Galectin Therapeutics
GALT
GALT
76 hedge funds and large institutions have $35.4M invested in Galectin Therapeutics in 2019 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 15 closing their positions.
Holders
76
Holders Change
+11
Holders Change %
+16.92%
% of All Funds
1.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
23
Reduced
14
Closed
15
Calls
$894K
Puts
$1.46M
Net Calls
-$567K
Net Calls Change
+$105K
Top Buyers
1 |
1
BlackRock
New York
|
$8.49M |
2 |
2
State Street
Boston,
Massachusetts
|
$2.14M |
3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$1.95M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$7.2M |
5 |
AG
5
Advisor Group
Phoenix,
Arizona
|
$3.35M |